124 related articles for article (PubMed ID: 30582799)
21. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
[TBL] [Abstract][Full Text] [Related]
22. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
23. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
[TBL] [Abstract][Full Text] [Related]
24. Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models.
Morimura O; Minami T; Kijima T; Koyama S; Otsuka T; Kinehara Y; Osa A; Higashiguchi M; Miyake K; Nagatomo I; Hirata H; Iwahori K; Takimoto T; Takeda Y; Kida H; Kumanogoh A
Biochem Biophys Res Commun; 2017 Jul; 488(4):596-602. PubMed ID: 28526406
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles Encapsulating Nitrosylated Maytansine To Enhance Radiation Therapy.
Gao S; Zhang W; Wang R; Hopkins SP; Spagnoli JC; Racin M; Bai L; Li L; Jiang W; Yang X; Lee C; Nagata K; Howerth EW; Handa H; Xie J; Ma Q; Kumar A
ACS Nano; 2020 Feb; 14(2):1468-1481. PubMed ID: 31939662
[TBL] [Abstract][Full Text] [Related]
26. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
[TBL] [Abstract][Full Text] [Related]
27. 6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib.
Liu Y; Lou G; Norton JT; Wang C; Kandela I; Tang S; Shank NI; Gupta P; Huang M; Avram MJ; Green R; Mazar A; Appella D; Chen Z; Huang S
FASEB J; 2017 Dec; 31(12):5453-5465. PubMed ID: 28821631
[TBL] [Abstract][Full Text] [Related]
28. Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity.
Wang H; Wu J; Xu L; Xie K; Chen C; Dong Y
Chem Commun (Camb); 2017 Feb; 53(17):2618-2621. PubMed ID: 28195282
[TBL] [Abstract][Full Text] [Related]
29. Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma.
Wang Z; Shao D; Chang Z; Lu M; Wang Y; Yue J; Yang D; Li M; Xu Q; Dong WF
ACS Nano; 2017 Dec; 11(12):12732-12741. PubMed ID: 29140684
[TBL] [Abstract][Full Text] [Related]
30. Gold nanoparticles application in liver cancer.
Taghizadeh S; Alimardani V; Roudbali PL; Ghasemi Y; Kaviani E
Photodiagnosis Photodyn Ther; 2019 Mar; 25():389-400. PubMed ID: 30684673
[TBL] [Abstract][Full Text] [Related]
31. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
Al-Saden N; Lam K; Chan C; Reilly RM
Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
[TBL] [Abstract][Full Text] [Related]
32. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
33. Polymer decorated gold nanoparticles in nanomedicine conjugates.
Capek I
Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
[TBL] [Abstract][Full Text] [Related]
34. Endoplasmic reticulum-targeted glutathione and pH dual responsive vitamin lipid nanovesicles for tocopheryl DM1 delivery and cancer therapy.
Wang YQ; Ji MY; Wang C
Int J Pharm; 2020 May; 582():119331. PubMed ID: 32289484
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
Feng L; Yao HP; Wang W; Zhou YQ; Zhou J; Zhang R; Wang MH
Clin Cancer Res; 2014 Dec; 20(23):6045-58. PubMed ID: 25294907
[TBL] [Abstract][Full Text] [Related]
36. Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.
Tovar V; Cornella H; Moeini A; Vidal S; Hoshida Y; Sia D; Peix J; Cabellos L; Alsinet C; Torrecilla S; Martinez-Quetglas I; Lozano JJ; Desbois-Mouthon C; Solé M; Domingo-Domenech J; Villanueva A; Llovet JM
Gut; 2017 Mar; 66(3):530-540. PubMed ID: 26658144
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
38. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
39. Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies.
Bao H; Zhang Q; Xu H; Yan Z
Int J Nanomedicine; 2016; 11():929-40. PubMed ID: 27022260
[TBL] [Abstract][Full Text] [Related]
40. α
Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
